PROXY STATEMENT

Company

UTAH MEDICAL PRODUCTS INC

Filed

April 12, 2021

Period of Report

April 9, 2021

Accession Number

0001096906-21-000735

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →